Status of R&D Portfolio for New Malaria Treatments.
Abstract
This presentation describes the work of the Medicines for Malaria Venture (MMV) in developing a variety of new antimalarial combination therapies, and its plans for future work.
Citation
Presentatation from: Scientific Symposium "Implementation of Artemisinin Combination Therapies (ACTs): Role of ASMQ". Rio de Janeiro, Brazil, 17 April 2008.
Links